MedPath

Safety Study of F2695 SR in Major Depressive Disorder

Phase 3
Completed
Conditions
Major Depressive Disorder
Interventions
Drug: F2695 SR
Registration Number
NCT01034267
Lead Sponsor
Forest Laboratories
Brief Summary

The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
828
Inclusion Criteria
  • Completed 1 of the lead-in studies LVM-MD-01, LVM-MD-02, or LVM-MD-03
  • Have normal examination findings at the final visit of the lead-in study
  • Have a negative serum pregnancy test at the final visit of the lead-in study if a woman of child-bearing potential
Exclusion Criteria
  • Any exclusionary psychiatric or medical condition that developed during the lead in study
  • Patients considered a suicide risk
  • Women who are pregnant, breastfeeding, or planning to become during the study OR are sexually active and not currently using a medically acceptable method of contraception

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1F2695 SR(Open-label) F2695 SR capsules, oral administration, once daily, flexible dosing
Primary Outcome Measures
NameTimeMethod
Adverse events, clinical laboratory tests, vital sign measurements, electrocardiograms, physical examinations, Columbia-Suicide Severity Rating Scale48 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (68)

Forest Investigative Site 55

🇺🇸

Dothan, Alabama, United States

Forest Investigative Site 29

🇺🇸

Scottsdale, Arizona, United States

Forest Investigative Site 31

🇺🇸

Beverly Hills, California, United States

Forest Investigative Site 3

🇺🇸

Costa Mesa, California, United States

Forest Investigative Site 12

🇺🇸

Encino, California, United States

Forest Investigative Site 6

🇺🇸

Escondido, California, United States

Forest Investigative Site 22

🇺🇸

Oceanside, California, United States

Forest Investigative Site 38

🇺🇸

Sherman Oaks, California, United States

Forest Investigative Site 36

🇺🇸

Denver, Colorado, United States

Forest Investigative Site 28

🇺🇸

Denver, Colorado, United States

Scroll for more (58 remaining)
Forest Investigative Site 55
🇺🇸Dothan, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.